Framingham general cardiovascular disease risk equation

Biomarker

1 paper2 findings

  • Humans1

Effects

2

High-risk classification

upin humans1

1 study
  1. Framingham general cardiovascular disease risk equation increases high-risk classification in humans (Framingham 20.2%, WHO/ISH 2.4%, ASCVD-PCE 4.8% of participants).

    “High risk ([≥]20%) was identified in 2.4%, 4.8%, and 20.2% of participants by WHO/ISH, ASCVD-PCE, and Framingham, respectively.”

    HumansEstimated 10-year cardiovascular disease risk ≥20%; university employees in India86.3% malesn = 124

    Cardiovascular Risk Stratification Among University Employees in India: Comparison of WHO/ISH, ASCVD and Framingham Risk Models

    medRxiv14 Oct 2026Preprint

More on High-risk classification

Estimated 10-year cardiovascular disease risk

upin humans1

1 study
  1. Framingham general cardiovascular disease risk equation increases estimated 10-year cardiovascular disease risk in humans (Mean estimated risk: Framingham 12.86%, WHO/ISH 5.94%, ASCVD-PCE 5.95%).

    “Mean estimated risk was 5.94% for WHO/ISH, 5.95% for ASCVD-PCE, and 12.86% for Framingham.”

    HumansUniversity employees in India without documented previous ischemic heart disease86.3% malesn = 124

    Cardiovascular Risk Stratification Among University Employees in India: Comparison of WHO/ISH, ASCVD and Framingham Risk Models

    medRxiv14 Oct 2026Preprint

More on Estimated 10-year cardiovascular disease risk

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 in 12 months